DEXTROSTAT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dextrostat, and what generic alternatives are available?
Dextrostat is a drug marketed by Shire and is included in one NDA.
The generic ingredient in DEXTROSTAT is dextroamphetamine sulfate. There are eighteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dextrostat
A generic version of DEXTROSTAT was approved as dextroamphetamine sulfate by BARR on January 31st, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DEXTROSTAT?
- What are the global sales for DEXTROSTAT?
- What is Average Wholesale Price for DEXTROSTAT?
Summary for DEXTROSTAT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 17 |
| DailyMed Link: | DEXTROSTAT at DailyMed |
US Patents and Regulatory Information for DEXTROSTAT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shire | DEXTROSTAT | dextroamphetamine sulfate | TABLET;ORAL | 084051-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Shire | DEXTROSTAT | dextroamphetamine sulfate | TABLET;ORAL | 084051-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
